Syntec Optics Holdings, Inc. Warrant

Syntec Optics (Nasdaq: OPTX) announced it received nearly $4 million in U.S. life sciences purchase orders for biomedical optical products, including applications in surgical robotics, DNA sequencing, and ophthalmology. This follows a previously announced $4.6 million order for laser blood analysis optics, demonstrating the company's expanding ro...

Starfighters Space (FJET) has been added to the Russell 3000® Index effective June 29, 2026, just seven months after its December 2025 IPO. The company operates a commercial fleet of supersonic F-104 aircraft from Kennedy Space Center and is developing STARLAUNCH, an airborne launch platform for space payloads. The June 2026 reconstitution also ...

Syntec Optics (Nasdaq: OPTX) announced the pricing of a $20 million underwritten public offering of 2,857,142 shares at $7.00 per share, with H.C. Wainwright & Co. as sole book-running manager. The offering is expected to close on April 30, 2026. Net proceeds will be used for acquisitions, investments in complementary businesses, working capital,...

Syntec Optics has surged 775% since late 2025, with technical indicators suggesting potential for further gains if it breaks above the $11.54 resistance level. The company, focused on polymer-based integrated optics and photonics, benefits from government contracts, defense supply chain onshoring, and growing demand from AI, data centers, and spa...

Syntec Optics reported Q3 2025 net sales of $7.0 million, a 6% increase from Q2, but experienced reduced gross profit and a net loss of $1.4 million. The company is focusing on yield improvements, scaling production, and expects Q4 revenue between $7.3-$8.0 million.